Metastatic cutaneous malignant melanoma: spectrum of imaging findings and the role of multimodality imaging.
AffiliationDepartment of Radiology, The Christie NHS Foundation Trust, Wilmslow Road, Manchester, UK.
MetadataShow full item record
AbstractCutaneous malignant melanoma is one of the most lethal and widely metastasising cancers with unpredictable pathways of spread. One of the most significant factors associated with survival in patients who have distant metastases is the number of organ sites involved. Innovative treatment options are now available for metastatic melanoma, and diagnostic imaging has become crucial for accurate staging and restaging of disease. The objective of this pictorial review is to illustrate the imaging spectrum of metastatic cutaneous malignant melanoma including both the common and the relatively ubiquitous sites of involvement using both conventional cross-sectional and metabolic molecular imaging. This review also highlights the importance of combining multiple imaging methods for accurate staging of metastatic melanoma.
CitationMetastatic cutaneous malignant melanoma: spectrum of imaging findings and the role of multimodality imaging. 2009, 53 (5):467-78; quiz 478-9 J Med Imaging Radiat Oncol
JournalJournal of Medical Imaging and Radiation Oncology
- Role of imaging methods in metastatic melanoma.
- Authors: Li Q, Yang J
- Issue date: 2012
- Imaging of abdominal manifestations of melanoma.
- Authors: Kamel IR, Kruskal JB, Gramm HF
- Issue date: 1998 Dec
- Multimethod imaging, staging, and spectrum of manifestations of metastatic melanoma.
- Authors: Patnana M, Bronstein Y, Szklaruk J, Bedi DG, Hwu WJ, Gershenwald JE, Prieto VG, Ng CS
- Issue date: 2011 Mar
- Metastatic pathways and time courses in the orderly progression of cutaneous melanoma.
- Authors: Meier F, Will S, Ellwanger U, Schlagenhauff B, Schittek B, Rassner G, Garbe C
- Issue date: 2002 Jul
- Prospective comparison of the impact on treatment decisions of whole-body magnetic resonance imaging and computed tomography in patients with metastatic malignant melanoma.
- Authors: Müller-Horvat C, Radny P, Eigentler TK, Schäfer J, Pfannenberg C, Horger M, Khorchidi S, Nägele T, Garbe C, Claussen CD, Schlemmer HP
- Issue date: 2006 Feb